SBI Healthcare Opportunities Fund Direct Growth
Equity
Direct
Sector - Healthcare
About the Fund
SBI Healthcare Opportunities Fund Direct Growth is an equity fund. This fund was started on 1 January, 2013. The fund is managed by Tanmaya Desai, Mohit Jain. The fund could potentially beat inflation in the long-run.
Key Parameters
- SBI Healthcare Opportunities Fund Direct Growth has ₹2760 Cr worth of assets under management (AUM) as on Jun 2024 and is more than category average.
- The fund has an expense ratio 0.9.
Returns
SBI Healthcare Opportunities Fund Direct Growth has given a CAGR return of 18.26% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 38.05%, 17.23% and 29.49% respectively.
Holdings
SBI Healthcare Opportunities Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Max Healthcare Institute Ltd Ordinary Shares, Divi's Laboratories Ltd, Cipla Ltd, Lonza Group Ltd ADR
Taxation
As it is a sector - healthcare mutual fund the taxation is as follows:For short term (less than a year) capital gains will be taxed at 15%For long term (more than 1 year) capital gains will be taxed at 10% without indexation benefitDividends will always be taxed at slab rate. Gains upto Rs 1 lakh are exempt in case of long term.
Investment objective of SBI Healthcare Opportunities Fund Direct Growth
To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Minimum Investment and lockin period
Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 500.00. SBI Healthcare Opportunities Fund Direct Growth has no lock in period.
Fund Performance
2181 people have invested ₹ 1.6Cr in SBI Healthcare Opportunities Fund Direct Growth in the last three months
INDmoney Rank
Powered by IND quant engine
IND ranking is not available for this fund.
Beats FD returns for both 3Y & 5Y duration
No bad points found for this fund.
Fund Overview
| Expense ratio | 0.94% |
Benchmark | S&P BSE Healthcare PR |
| AUM | ₹2760 Cr |
| Inception Date | 1 January, 2013 |
| Min Lumpsum/SIP | ₹5000/₹500 |
Exit Load | 0.5% |
| Lock In | No Lock-in |
TurnOver | 32% |
| Risk |   Very High Risk |
Fund Distributionas on (30-Jun-24)
Large cap
38.9%
Small cap
30.6%
Mid cap
28.8%
Sector Allocation
Health
92.7%
Basic Materials
7.3%
All changes are between Apr'24 and Jun'24
as on (30-Jun-24)
Holdings | Weight% | 1M Change | |
|---|---|---|---|
 Sun Pharmaceuticals Industries Ltd | 13.78% | 4.2% | |
 Max Healthcare Institute Ltd Ordinary Shares | 7.67% | -6.3% | |
 Divi's Laboratories Ltd | 6.66% | 0% | |
 Cipla Ltd | 6.65% | 0% | |
 Lonza Group Ltd ADR | 4.94% | 0% |
See all
See all
Returns for the month of Jun
Top Growth Drivers | 1M Return |
|---|---|
 Sun Pharmaceuticals Industries Ltd | 7.2% |
 Max Healthcare Institute Ltd | 4.2% |
 Aether Industries Ltd | 1.4% |
Tanmaya Desai
Fund Manager of SBI Healthcare Opportunities Fund Direct Growth, since 1 June 2011
Top funds managed
Mohit Jain
Fund Manager of SBI Healthcare Opportunities Fund Direct Growth, since 30 November 2017
Top funds managed
Mutual Fund Insights
Over the last 1 year, this fund has decreased expense ratio by 12.1% moving from 1.07 to 0.94.
This fund has one of the lowest expense ratio in the category (sector - healthcare). Its expense ratio is 0.94% which is lower than the category average expense ratio of 1.42%.
In the last 3 years, ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth has given 18.75% return, outperforming this fund by 1.52% per annum.
In the last 1 year, Quant Healthcare Fund Direct Growth has given 60.96% return, outperforming this fund by 22.91%.
Over the last 6 months, this fund has experienced a 22.0% growth in AUM moving from 2.26K Cr to 2.76K Cr.
In the last 5 years, DSP Healthcare Fund Direct Growth has given 31.51% return, outperforming this fund by 2.02% per annum.
SBI Healthcare Opportunities Fund Direct Growth Highlights
Very High Risk
Investors understand that their principal will be at Very High Risk
About the fund
This fund has delivered an average annual returns of 18.26% since inception which is less than its category average return of 23.79%
Fund Allocations
This fund has an allocation of 98.36% in Equity, 0% in Debt and 1.64% in Cash related instruments
AUM size ₹2760 Cr
This fund has AUM of ₹2760 Cr which is more than its category average of ₹ 1743 Cr
Expense Ratio 0.94%
This fund has an expense ratio of 0.94% which is less than its category average expense ratio of 1.44%
Frequently Asked Questions
The current NAV of SBI Healthcare Opportunities Fund Direct Growth is ₹418.34 as on 24-Jul-2024.
Existing (Absolute + CAGR) as on 24-Jul-2024.
SBI Healthcare Opportunities Fund Direct Growth | Absolute Returns | CAGR Returns |
1 Month Returns | 4.2% | 4.2% |
6 Month Returns | 15.19% | 15.19% |
1 Year Returns | 38.05% | 38.05% |
3 Years Returns | 61.1% | 17.23% |
5 Years Returns | 264.07% | 29.49% |
With INDmoney, the process of investing is very simple and involves zero commission.
- Click Buy on the fund name.
- Input the amount you are looking to invest.
- Select Lump Sum or SIP (Weekly, Monthly or Quarterly).
- Select your bank account and proceed with Payment.
0.94% as on June 2024
₹2760 Cr as on June 2024
Sun Pharmaceuticals Industries Ltd(13.78%), Max Healthcare Institute Ltd Ordinary Shares(7.67%), Divi's Laboratories Ltd(6.66%), Cipla Ltd(6.65%), Lonza Group Ltd ADR(4.94%) as on June 2024
The alpha ratio for the SBI Healthcare Opportunities Fund Direct Growth for various period is as follows:
Fund Name | Alpha 1 Year | Alpha 3 Years | Alpha 5 Years |
SBI Healthcare Opportunities Fund Direct Growth | 0.7 | 3.42 | 5.11 |
As on June 2024
The alpha for SBI Healthcare Opportunities Fund Direct Growth is calculated against S&P BSE Healthcare PR. Higher alpha indicates that this fund has generated extra returns compared to the benchmark index. An alpha of 1.0 means the fund has outperformed its benchmark index by 1%.
The Beta ratio for the SBI Healthcare Opportunities Fund Direct Growth for various period is as follows:
Fund Name | Beta 1 Year | Beta 3 Years | Beta 5 Years |
SBI Healthcare Opportunities Fund Direct Growth | 0.87 | 0.89 | 0.87 |
As on June 2024
The Beta for SBI Healthcare Opportunities Fund Direct Growth is calculated with S&P BSE Healthcare PR. Beta tells the volatility of the mutual fund relative to its benchmark. If the beta of a mutual fund is more than 1, then the mutual fund is more volatile than its benchmark. If beta is less than 1, then the mutual fund is less volatile than the benchmark.
The sharpe ratio for the SBI Healthcare Opportunities Fund Direct Growth for various period is as follows:
Fund Name | Sharpe Ratio 1 Year | Sharpe Ratio 3 Years | Sharpe Ratio 5 Years |
SBI Healthcare Opportunities Fund Direct Growth | 2.06 | 0.79 | 1.23 |
As on June 2024
The sharpe ratio for SBI Healthcare Opportunities Fund Direct Growth is calculated with S&P BSE Healthcare PR. Sharpe ratio tells risk-adjusted-returns of the mutual fund. The higher a fund's Sharpe ratio, the better a fund's returns have been relative to the risk it has taken on.
The standard deviation for the SBI Healthcare Opportunities Fund Direct Growth for various period is as follows:
Fund Name | Standard Deviation 1 Year | Standard Deviation 3 Years | Standard Deviation 5 Years |
SBI Healthcare Opportunities Fund Direct Growth | 13.71 | 14.19 | 17.43 |
As on June 2024
Standard deviation tells the volatility of the returns of the mutual fund. The higher a fund's Standard deviation, the higher the volatility of the fund's returns.
Sortino ratio is 1.32 as on June 2024. Sortino ratio tells the downside risk-adjusted-returns of the mutual fund.
Information ratio is 0.78 as on June 2024. It tells the consistency of the fund in generating superior risk-adjusted performance
Tanmaya Desai, Mohit Jain are the fund managers of SBI Healthcare Opportunities Fund Direct Growth
The Exit load of SBI Healthcare Opportunities Fund Direct Growth is 0.5%